Although COVID-19 has been somewhat controlled, it is still present in forms of different strains, which is why Pfizer, ...

On Thursday, Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $12.9 which represents a slight increase of $0.22 or 1.74% from the prior close of $12.68. The stock opened at $12.6 and ...

Novavax (NVAX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Mayank Mamtani ...

This health news roundup covers various topics including Gerresheimer's stock jump due to an activist investor, a US list of ...

Novavax Inc (NVAX) reports significant revenue from Sanofi partnership and outlines strategic shifts to enhance future growth ...

Novavax, Inc. (NVAX) announced Wednesday that the European Commission granted Marketing Authorization for Novavax's updated 2024-2025 ...

Novavax's vaccine is also authorized for use in the U.S., and is in line with guidance from the U.S. Food and Drug ...

The European Commission authorized Novavax's updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, ...

In terms of valuation, Novavax Inc’s market capitalization stands at $2.18 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value.

The mRNA-based supplier of vaccines profited from Covid-19 vaccine sales. As the years passed, Covid evolved. The weaker ...

We recently compiled a list of the 10 High-Flying Stocks to Buy Now. In this article, we are going to take a look at where ...

Novavax (NVAX) stock fell after a clarification on an analyst report led to a sharp rally in the company stock in the ...